抗原递呈细胞的英文

• antigen presenting cell

• "抗原"英文翻译    -抗体反应 antigen-antibody react ...
• "递"英文翻译    hand over; pass; give
• "呈"英文翻译    assume
• "细胞"英文翻译    cell; sytes; bioplast; cella ...
• "专职抗原递呈细胞" 英文翻译 :    cellule de transport professionel de l'antigène
• "非专业性抗原递呈细胞" 英文翻译 :    nonprofessional apc
• "抗原递呈" 英文翻译 :    apc
• "抗原提呈细胞" 英文翻译 :    antigen presenting cell, apc; antigen processing cell
• "抗原提呈细胞,呈递抗原细胞" 英文翻译 :    antigen presenting cell
• "b细胞抗原" 英文翻译 :    b cell antigen
• "t细胞抗原" 英文翻译 :    t antigen
• "白细胞抗原" 英文翻译 :    hla; leucocyte antigen; leukocyte antigen; white blood cell antigen; white cell antigen
• "红细胞t抗原" 英文翻译 :    t antigen
• "红细胞抗原" 英文翻译 :    erythrocyte antigen; red cell antigens
• "浆细胞抗原" 英文翻译 :    plasma cell antigen
• "人白细胞a抗原" 英文翻译 :    human leukocyte antigen a
• "人类t细胞抗原" 英文翻译 :    human t lymphocyte antigen
• "人细胞抗原" 英文翻译 :    htla
• "体细胞抗原" 英文翻译 :    somaticantigen
• "细胞壁抗原" 英文翻译 :    cell wall antigen
• "细胞浆抗原" 英文翻译 :    cytoplasmic antigen
• "细胞抗原" 英文翻译 :    cell antigen
• "细胞膜抗原" 英文翻译 :    cell membrane autigen
• "细胞内抗原" 英文翻译 :    intracellular antigen
• "细胞外抗原" 英文翻译 :    extracellular antigen

• We used pbmc - derived dc loaded with apoptotic daudi cells , which were irradiated by 60co y after incubation with agonist cd40mab ( 5cl 1 , 5 ? g / ml ) for 24h
  树突状细胞( dc )是体内功能最强的专职抗原递呈细胞，在机体免疫应答中起极其重要的作用。
• Tumor cell - derived exosomes containing tumor antigens and mhc class i molecule could present tumor antigens to dcs and induce cd8 + t cell - dependent antitumor immune responses significantly
  其含有mhc类分子和lamp - 1 ，能够将肿瘤抗原呈递给抗原递呈细胞，产生显著的cd8 ~ + t细胞依赖的抗肿瘤免疫反应。
• Dendritic cells ( dc ) , the initiator and modulator of immune response , are the most powerful professional antigen - presenting cells ( apc ) . recent studies indicated that dc have the most power to activate tumor specific ctl , therefore , dc are applied in the therapy of tumors , e
  机体的抗肿瘤免疫主要为t淋巴细胞所介导， t细胞的致敏、激活、扩增和对肿瘤细胞的杀伤作用均有赖于抗原递呈细胞肿瘤递呈相应的抗原肽及相关因子的参与。
• Methods employed to prepare vaccine include rumor cells genetically modified with cytokines , costimulatory molecules and tumor antigenic peptides , dendritic cells ( dc ) primed with tumor antigens in vitro or genetically modified with tumor antigens , or fusion of tumor cells with antigen presenting cells ( apc )
  现有的比较受到关注的制备肿瘤疫苗的方法有各种细胞因子、共刺激分子、肿瘤抗原肽等基因修饰的肿瘤细胞疫苗；体外抗原致敏的或肿瘤抗原肽基因修饰的树突状细胞疫苗；肿瘤细胞与抗原递呈细胞融合疫苗等。